Nucleus incertus contributes to an anxiogenic effect of buspirone in rats: Involvement of 5-HT1A receptors

被引:23
作者
Kumar, Jigna Rajesh [1 ,2 ,3 ,4 ]
Rajkumar, Ramamoorthy [1 ,2 ,3 ]
Lee, Liying Corinne [1 ,2 ,3 ]
Dawe, Gavin S. [1 ,2 ,3 ,4 ]
机构
[1] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117600, Singapore
[2] Natl Univ Singapore, Inst Life Sci, Neurobiol & Ageing Programme, Singapore 117456, Singapore
[3] Singapore Inst Neurotechnol SINAPSE, Singapore 117456, Singapore
[4] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn NGS, Singapore 117456, Singapore
基金
英国医学研究理事会;
关键词
Buspirone; Nucleus incertus; Anxiogenic; 5-HT1A receptors; D-2; receptors; ELEVATED PLUS-MAZE; CORTICOTROPIN-RELEASING-FACTOR; IMMEDIATE-EARLY GENE; C-FOS; ADENYLATE-CYCLASE; PHARMACOLOGICAL CHARACTERIZATION; POTENTIATED STARTLE; DORSAL HIPPOCAMPUS; LOCUS-COERULEUS; PANIC DISORDER;
D O I
10.1016/j.neuropharm.2016.07.019
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The nucleus incertus (NI), a brainstem structure with diverse anatomical connections, is implicated in anxiety, arousal, hippocampal theta modulation, and stress responses. It expresses a variety of neurotransmitters, neuropeptides and receptors such as 5-HT1A, D-2 and CRF1 receptors. We hypothesized that the NI may play a role in the neuropharmacology of buspirone, a clinical anxiolytic which is a 5-HT1A receptor partial agonist and a D-2 receptor antagonist. Several preclinical studies have reported a biphasic anxiety-modulating effect of buspirone but the precise mechanism and structures underlying this effect are not well-understood. The present study implicates the NI in the anxiogenic effects of a high dose of buspirone. Systemic buspirone (3 mg/kg) induced anxiogenic effects in elevated plus maze, light-dark box and open field exploration paradigms in rats and strongly activated the NI, as reflected by c-Fos expression. This anxiogenic effect was reproduced by direct infusion of buspirone (5 mu g) into the NI, but was abolished in NI-CRF-saporin-lesioned rats, indicating that the NI is present in neural circuits driving anxiogenic behaviour. Pharmacological studies with NAD 299, a selective 5-HT1A antagonist, or quinpirole, a D-2/D-3 agonist, were conducted to examine the receptor system in the NI involved in this anxiogenic effect. Opposing the 5-HT1A agonism but not the D-2 antagonism of buspirone in the NI attenuated the anxiogenic effects of systemic buspirone. In conclusion, 5-HT1A receptors in the NI contribute to the anxiogenic effect of an acute high dose of buspirone in rats and may be functionally relevant to physiological anxiety. (C) 2016 The Authors. Published by Elsevier Ltd.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 50 条
[31]   BUSPIRONE INHIBITS CORTICOTROPIN-RELEASING FACTOR AND STRESS-INDUCED CECAL MOTOR RESPONSE IN RATS BY ACTING THROUGH 5-HT1A RECEPTORS [J].
MARTINEZ, JA ;
BUENO, L .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 202 (03) :379-383
[32]   Involvement of spinal 5-HT1A receptors in isolation rearing-induced hypoalgesia in mice [J].
Horiguchi, Naotaka ;
Ago, Yukio ;
Asada, Kazuki ;
Kita, Yuki ;
Hiramatsu, Naoki ;
Takuma, Kazuhiro ;
Matsuda, Toshio .
PSYCHOPHARMACOLOGY, 2013, 227 (02) :251-261
[33]   Involvement of spinal 5-HT1A receptors in isolation rearing-induced hypoalgesia in mice [J].
Naotaka Horiguchi ;
Yukio Ago ;
Kazuki Asada ;
Yuki Kita ;
Naoki Hiramatsu ;
Kazuhiro Takuma ;
Toshio Matsuda .
Psychopharmacology, 2013, 227 :251-261
[34]   5HT1A and 5HT1B receptors of medial prefrontal cortex modulate anxiogenic-like behaviors in rats [J].
Solati, Jalal ;
Salari, Ali-Akbar ;
Bakhtiari, Amir .
NEUROSCIENCE LETTERS, 2011, 504 (03) :325-329
[35]   INVOLVEMENT OF 5-HT1A AND 5-HT2 RECEPTORS OF THE INFERIOR COLLICULUS IN AVERSIVE STATES INDUCED BY EXPOSURE OF RATS TO THE ELEVATED PLUS-MAZE TEST [J].
MELO, LL ;
BRANDAO, ML .
BEHAVIOURAL PHARMACOLOGY, 1995, 6 (04) :413-417
[36]   Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience [J].
Pokorny, Thomas ;
Preller, Katrin H. ;
Kraehenmann, Rainer ;
Vollenweider, Franz X. .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (04) :756-766
[37]   The therapeutic role of 5-HT1A and 5-HT2A receptors in depression [J].
Celada, P ;
Puig, MV ;
Amargós-Bosch, M ;
Adell, A ;
Artigas, F .
JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2004, 29 (04) :252-265
[38]   Imipramine but not 5-HT1A receptor agonists or neuroleptics induces adaptive changes in hippocampal 5-HT1A and 5-HT4 receptors [J].
Zahorodna, A ;
Tokarski, K ;
Bijak, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 443 (1-3) :51-57
[39]   Interaction between estradiol and 5-HT1A receptors in the median raphe nucleus on acquisition of aversive information and association to the context in ovariectomized rats [J].
Carneiro Spera de Andrade, Telma Goncalves ;
dos Santos Silva, Joao Victor ;
Batistela, Matheus Fitipaldi ;
Frei, Fernando ;
Sant'Ana, Ana Beatriz .
NEUROBIOLOGY OF STRESS, 2017, 7 :80-88
[40]   Conformational analysis and geometry optimization of buspirone-A 5-HT1A receptor agonist [J].
Ikram, Huma ;
Azhar, Muhammad ;
Jameel, Muhammad ;
Bano, Khalida .
PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 27 (05) :1515-1522